
     RDKit          2D

 12 12  0  0  0  0  0  0  0  0999 V2000
    3.7934    2.2688    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500   -2.2688    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0790    1.0313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7934    1.4438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0790    0.2063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3644   -0.2063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3644   -1.0313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5079    2.6812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0790   -1.4438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500   -1.4438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0790   -2.2688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3644   -2.6812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0
  1  8  1  0
  2 10  2  0
  2 12  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  9  2  0
  7 10  1  0
  9 11  1  0
 11 12  2  0
M  END
>  <DRUGBANK_ID>  (1) 
DB05855

>  <COMMON_NAME>  (1) 
Rivanicline

>  <CAS_NUMBER>  (1) 
15585-43-0

>  <UNII>  (1) 
6H35LF645A

>  <SYNONYMS>  (1) 
(3E)-N-methyl-4-(pyridin-3-yl)but-3-en-1-amine; (E)-metanicotine; (E)-N-Methyl-4-(3-pyridinyl)-3-butene-1-amine; N-methyl-4-(3-pyridinyl)-(3E)-3-buten-1-amine; Rivanicline; trans-metanicotine

$$$$
